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Abstract
We describe a simple and reproducible method to measure absolute telomere length (aTL) using quantitative real-
time polymerase chain reaction (qPCR). This method is based on the Cawthon method for relative measurement of
telomere length (TL) but modified by introducing an oligomer standard to measure aTL. The method describes the
oligomer standards, the generation of the standard curve and the calculations required to calculate aTL from the
qPCR data. The necessary controls and performance characteristics of the assay are described in detail and
compared relative to other methods for measuring TL. Typical results for this assay for a variety of human tissue
samples are provided as well as a troubleshooting schedule. This method allows high throughput measurement of
aTL using small amounts of DNA making it amenable for molecular epidemiological studies. Compared to the
traditional relative TL qPCR assays, the aTL method described in this protocol enables a more direct comparison of
results between experiments within and between laboratories.
Introduction
Telomeres are nucleoprotein structures that cap the ends
of chromosomes. The integrity of the telomere structure
and its DNA hexamer (TTAGGG)n repeat sequence is
critical for the protection of the ends of chromosomes
from degradation and in maintaining overall genomic
stability [1,2]. The number of DNA hexamer (TTAGGG)
n repeats is reduced during each cell division in differen-
tiated cells, and as a consequence telomere length (TL)
often decreases in most differentiated cells throughout
the lifespan of the organism [1]. Shortening of telomeres
can result in telomere end fusions and an increased level
of chromosome instability (CIN), which is in turn a key
initiating event in numerous cancers (including lung,
breast, colon, and prostate cancers, as well as certain leu-
kaemia’s) [3-7]. It has been shown that telomere shorten-
ing can be accelerated by environmental factors such as
psychological and physiological stress, cigarette smoking,
obesity and high homocysteine [8-14]. Efficiency of TL
maintenance is also affected by gender [15-17]. TL has
been shown to be associated prospectively with increased
risk of myocardial infarction, coronary artery disease,
breast cancer free survival, clear cell renal cell carcinoma
survival, post-stroke mortality, dementia and cognitive
decline, as well as total survival independent of genetic
influences [18-24].
For all of these reasons there has been a burgeoning
interest in measuring TL accurately and efficiently to
understand both the fundamental biology of telomere
maintenance as well as determining the modifiable dietary
and life-style factors that contribute substantially to accel-
erated TL attrition. A wide range of methods have been
developed to measure TL such as (i) the gold standard
Terminal Restriction Fragment (TRF) analysis by hybridi-
sation of digested DNA with telomere sequence probes,
(ii) Flow-FISH cytometry of cells following hybridisation
with fluorescent peptide nucleic acid (PNA) probes,
(iii) quantitative fluorescence in situ hybridisation (FISH)
with fluorescent telomere PNA probes and (iv) qPCR
assay. With the exception of the TRF assay all other meth-
ods have the disadvantage of generating a relative measure
of TL. The advantage of the qPCR method is that, unlike
t h eT R Fa s s a yo n l ys m a l la m o u n t so fD N Aa r er e q u i r e d
and can easily be performed in high-throughput format
which is essential for large epidemiological studies [25,26].
The protocol we describe is a modification to Cawthon’s
qPCR based relative quantification (Telomere/Single Copy
Gene ratio) method by introducing an oligomer standard
to generate aTL values. The capability to generate aTL
values allows a more direct comparison of results between
experiments within and between laboratories. The protocol
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phocytes but can be easily adapted to other cell types or
species.
Experimental design
The measurement of aTL can be performed in any cell
population from which high quality undamaged DNA
can be collected. However the possibility of detecting
meaningful differences between groups is likely to
depend on the purity of the cell populations examined
because of the possibility of different replicative histories
which may affect TL. This is particularly true when doing
in vivo studies with white blood cells because the ratios
of lymphocytes, monocytes, basophils and granulocytes
can vary greatly between individuals depending on their
age and health condition(s). Therefore aTL should be
measured in populations of single cell types as much as is
practically possible. Other sources of variation could be
the proportion of dead/dying cells which may have to be
taken into consideration because necrotic or apoptotic
cells may have a different TL from viable cells.
As indicated above there are an increasing demo-
graphic, nutritional and life-style variables and disease
conditions associated with altered TL and these need to
be considered when planning comparative in vivo stu-
dies. Below is a list of the key variables that should be
considered in human studies of aTL [8-13,18-24,27-29]:
Date of Birth (include maternal and paternal age at
birth)
Gender
History of cancer, cardiovascular disease and neuro-
degenerative disease
Inherited mutations that predispose to degenerative
diseases listed above as well as accelerated ageing
syndromes (e.g., WRN, ATM and BRCA1 mutations)
Medication or recent illness (disease history)
Smoking status and history
Exposure to chemical carcinogens and radiation e.g.,
X-ray
Indicators of psychological stress
Body Mass Index
Lifestyle index (e.g. physical activity, alcohol con-
sumption, sunshine exposure)
Dietary habits measured using a validated food fre-
quency questionnaire
Plasma concentration of B vitamins and
homocysteine
Markers of oxidative stress (CRP, MDA etc)
Genotype
Precautions regarding a qPCR based assay
Real-time quantitative PCR (qPCR) uses fluorescent sig-
nal detection to be monitored as the PCR reaction
proceeds. This allows initial template levels to be pre-
cisely and accurately quantified. PCR is an extremely
sensitive method of analysis and cross-contamination
can lead to erroneous or false results. Therefore precau-
tions and strict quality control ascertainment must be
planned into to each and every experiment (further
details can be found in [30]).
Materials
Reagents and Reagent Set-Up
Sample collection
Buccal cell buffer Prepare 1 litre of the buccal buffer,
[0.01 M Tris-hydrochloride (Sigma T-3253), 0.1 M ethy-
lenediaminetetraacetic acid tetra Na salt (Sigma E5391),
0.02 M sodium chloride (Sigma S5886)]. Thoroughly
dissolve the salts IN MilliQ water and make up the
volume to 1000 ml. Adjust pH to 7.0 and autoclave at
121°C for 30 min. Buffer will last for up to 3 months
when stored as a sterile solution in sealed bottles at
room temperature.
Dimethyl sulphoxide (DMSO) (Sigma, hybrimax, ster-
ile-filtered, #D2650).
Phosphate Buffered Saline (PBS)
Ficoll-Paque (GE Biosciences)
Hank’s balanced salt solutions (HBSS)
Fetal bovine serum (FBS), heat-inactivated
DNA isolation
All solutions used for DNA isolation are purged with
nitrogen (immediately prior to use) and supplemented
with 50 μM phenyl-tert-butyl nitrone to minimise oxida-
tive damage to DNA [31].
Qiagen DNAeasy Kit (#69506)
i n c l u d e s :P r o t e i n a s eK ,A W 1 ,A W 2 ,A Ea n dS p i n -
columns
Dithiothreitol (DTT; Sigma)
Ethanol (Ajax Finechem #214-2.5L)
Nitrogen (for purging of buffers)
Oligomers (standards and primers)
CRITICAL: All oligomers should be HPLC purified;
long oligomers (>50 mers) have a high failure rate dur-
ing synthesis; this means there will be multiple failed
sequences which must be removed in order to maintain
accuracy of oligomer standards (GeneWorks, Adelaide).
All oligomers are diluted in appropriate volume of PCR
grade water and stored at -20degC until required.
Working stocks of oligomers should be made fresh;
dilutions are stable at 4degC for up to 2 weeks. Oligo-
mer sequences are shown in Table 1.
Standard Curves and associated calculations
Telomere Standard Curve
A standard curve is established by dilution of known
quantities of a synthesised 84 mer oligonucleotide con-
taining only TTAGGG repeats. The number of repeats
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as follows:
￿ The oligomer standard is 84 bp in length
(TTAGGG repeated 14 times), with a molecular
weight (MW) of 26667.2.
￿ The weight of one molecule is MW/Avogadro’s
number. Therefore, weight of telomere standard is:
2.6667 × 10
4/6.02 × 10
23 = 0.44 × 10
-19g.
￿ The highest concentration standard (TEL STD A)
has 60 pg of telomere oligomer (60 × 10
-12g) per
reaction.
￿ Therefore there are 60 × 10
-12/0.44 × 10
-19 =1 . 3 6
×1 0
9 molecules of oligomer in TEL STD A.
￿ T h ea m o u n to ft e l o m e r es e q u e n c ei nT E LS T DA
is calculated as: 1.36 × 10
9 × 84 (oligomer length) =
1.18 × 10
8 kb of telomere sequence in TEL STD A.
A standard curve is generated by performing the aTL
qPCR assay on serial dilutions of TEL STD A (10
-1 [1.18 ×
10
8] through to 10
-6 [1.18 × 10
3] dilution).
Plasmid DNA (pBR322) is added to each standard to
maintain a constant 20 ng of total DNA per reaction
tube. The standard curve was used to measure content
of telomeric sequence per sample in kb (Figure 1).
Single copy gene (SCG) standard
A single copy gene (SCG) is used as a control for amplifica-
tion for every sample performed and to determine genome
copies per sample. The choice of SCG is critical for reliabil-
ity of results; any change in copy number can substantially
impact upon aTL measurements. We routinely use 36B4,
which encodes the acidic ribosomal phosphoprotein P0; b-
globin is also frequently used. NOTE: Remember that
although telomeric DNA sequence is consistent in mam-
mals, the SCG will be different, thus a SCG standard curve
and amplicon must be generated for each target species.
CRITICAL: SCG amplification is crucial for the accuracy
of the results generated in the aTL qPCR assay; changes in
amount of template that is present in each reaction can by
affected by pipetting or DNA quantification error. Varia-
tion in SCG copy number (CNV) may also occur between
individuals and between normal and cancerous cells; CNV
can be assessed by using multiple SCG amplicons to gen-
erate diploid copies per PCR reaction.
Standard curve for human SCG, 36B4
Genome copy number per reaction is calculated as fol-
lows:
￿ The synthesised 36B4 oligomer standard is 75 bp
in length with a MW of 23268.1.
￿ The weight of one molecule is MW/Avogadro’s
number. Therefore, weight of the synthesised 36B4
oligomer standard is: 2.32681 × 10
4/6.02 × 10
23 =
0.38 × 10
-19g.
￿ The highest concentration standard (SCG STD A) had
200 pg of 36B4 oligomer (200 × 10
-12g) per reaction.
￿ Therefore there are 200 × 10
-12/0.38 × 10
-19 = 5.26
×1 0
9 copies of 36B4 amplicon in SCG STD A.
￿ Therefore SCG STD A is equivalent to 2.63 × 10
9
diploid genome copies, because there are two copies
of 36B4 per diploid genome.
A standard curve was generated by performing serial
dilutions of SCG STD A (10
-1 through to 10
-6dilution).
Plasmid DNA (pBR322) was added to each standard to
maintain a constant 20 ng of total DNA per reaction
tube. The standard curve was used to measure diploid
genome copies per sample (Figure 1).
PCR
Power SYBR I mastermix (Applied Biosystems, #4367396).
Contains AmpliTaq Gold DNA polymerase, dNTPs, SYBR
I Green Dye, opitimised buffers and passive reference dye
(ROX) - CAUTION SYBR I Green dye may be carcino-
genic when ingested or absorbed into skin. Wear appro-
priate gloves when working with this solution.
Table 1 Oligomers used for aTL assay in human and rodent
Oligomer Name Species Oligomer sequence (5’-3’) Amplicon size
Standards Telomere standard Human/rodent (TTAGGG)14 84 bp
36B4 standard Human CAGCAAGTGGGAAGGTGTAATCCGTCTCCACAGACAAGGCCAGGACTCGTTTG
TACCCGTTGATGATAGAATGGG
75 bp
PCR Primers teloF Human/rodent CGGTTTGTTTGGGTTTGGGTTTGGGTTTGGG TTTGGGTT >76 bp
teloR Human/rodent GGCTTGCCTTACCCTTACCCTTACCC TTACCCTTACCCT
36B4F Human CAGCAAGTGGGAAGGTGTAATCC 75 bp
36B4R Human CCCATTCTATCATCAACGGGTACAA
b-globinF Human GCTTCTGACACAACTGTGTTCACTAGC 82 bp
b-globinR Human CACCAACTTCATCCACGTTCACC
36B4F Rodent ACTGGTCTAGGACCCGAGAAG 78 bp
36B4R Rodent TCAATGGTGCCTCTGGAGATT
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Long telomere positive control DNA (cell line 1301;
accession number 01051619, European Collection of
Cell Cultures, UK EQUIPMENT)
Plasmid DNA PBR322 (Sigma)
Equipment
Sample collection
Biological safety cabinet.
Bench top centrifuge, biosafe.
Haemocytometer
30 ml yellow topped polystyrene containers (Sarstedt
#60.9922.918).
10 ml graduated sterile pipettes (Falcon #7551).
Milli-Q water (Milli-Q water purification system, Ade-
lab Scientific, SA).
Sterile plugged Pasteur pipettes 900 (22-23 cm) (Chase
#93P).
Syringes 10 ml (Crown Scientific #SS + 10S).
Needles 18G (Crown Scientific # 2525RA).
Lymphocytes Sterile vacutainer blood tubes with lithium
heparin or EDTA (e.g. Greiner)
Buccal Small headed toothbrushes (2 cm head length)
(Supply SA, #85300012).
Nylon net filters 100 μm (Millipore, #MILNYH02500).
DNA isolation
Benchtop micro-centrifuge
Nitrogen
Heat-block
1.5 ml microfuge tubes, DNAse free.
PCR plates and caps
Spectrophotometer for 260/280-nm measurements (i.e.
NanoDrop, Biolabs)
PCR
Pipettes (and tips)
Optical PCR plates and caps
Centrifuge for spinning plates
Real-Time PCR machine (e.g. Applied Biosystems 7300)
Software for analyzing data (e.g. Applied Biosystems
SDS software v1.4)
Software for analyzing data (e.g. Microsoft Excel,
SPSS)
Procedure
Sample collection
The measurement of aTL can be performed in any cell
population from which high quality undamaged DNA can
be collected. Below are some examples of collection proce-
dures we routinely use in our research. All manipulations
must be carried out in a Biological Safety Cabinet Class II.
Lymphocytes
I. Collect fresh blood by venipuncture into vacutai-
ner blood tubes (LiHep or EDTA).
II. Dilute whole blood 1:1 with HBSS and gently
invert to mix
III. Overlay diluted blood onto 1/3 volume of Ficoll-
Paque being careful not to disturb the interface
IV. Centrifuge tubes at 400 g for 30 min at 20degC
V. Remove lymphocyte layer located at the interface
of Ficoll-Paque and dilute plasma into a fresh tube
using a Pasteur pipette.
B
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Figure 1 Standard curve used to calculate absolute telomere
length.C T (cycle threshold) is the number of PCR cycles for which
enough SYBR green fluorescence was detected above background.
A) Graph shows standard curve for calculating length of telomere
sequence per reaction tube. X-axis represents amount of telomere
sequence in kb per reaction. Correlation coefficient within the linear
range was 0.98. The graph shown here represents the linear range
of the PCR. The DNA amount was optimised so that experimental
samples are detected within the linear range. The value generated
from the experimental samples utilising this standard curve was
equal to kb of telomere sequence per sample. B) Graph shows
standard curve for calculating genome copies using 36B4 copy
number. Correlation coefficient was 0.99. Standard curves were
generated using an AB 7300 Sequence Detection System with the
SDS Ver. 1.9 software (Applied Biosystems, Foster City, CA).
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at room temperature
VII. Centrifuge at 180 g for 10 min
VIII. Discard supernatant and resuspend the cell
pellet in HBSS.
IX. Perform cell count and viability test using
haemocytometer and trypan blue
X. Centrifuge at 100 g for 10 min.
PAUSE POINT: Cells can be resuspended in 200 μl
PBS and taken through to DNA isolation step
below or if storage required proceed to step XI.
XI. Discard supernatant and resuspend the cell pellet
in freezing media (FBS and 10%DMSO) resuspend at
5×1 0
6 cells/ml
XII. Place in Styrofoam box at -80degC.
XIII. Transfer to Liquid Nitrogen for long term sto-
rage until required
a. Cells can be stored for up to 10 years.
XIV. To thaw cells, remove from liquid nitrogen and
place on ice
XV. Place vial in a beaker of 37degC water and agi-
tate gently.
XVI. Once completely thawed, centrifuge vial for 5
min at 300 g.
XVII. Discard supernatant and resuspend pellet in
200 μl PBS
Buccal cells
I. Prior to buccal cell collection rinse mouth twice
thoroughly with 100 ml of water.
II. Gently rotate a small-headed toothbrush (2 cm
head length) 10 times firmly against the inside of the
cheek wall in a circular motion.
III. The head of each brush is then placed into
10 ml of buffer and rotated repeatedly such that
the cells are dislodged and released into buffer pro-
ducing a cloudy suspension of buccal cells in the
buffer.
IV. Centrifuge for ten minutes at 100 g.
V. Remove supernatant leaving approximately 1 ml
of cell suspension and replace with another 5 ml of
buccal buffer. Vortex briefly.
VI. Centrifuge at 100 g for ten minutes.
VII. Remove supernatant and resuspend in 5 mls of
buccal buffer.
VIII. Vortex briefly and then homogenise for
2-3 minutes in a hand held tissue homogenizer to
disaggregate cell clumps.
IX. Draw cells up into a syringe (with 18G needle)
and pass through a 100 μm nylon filter into a fresh
tube.
X. Centrifuge at 100 g for 10 mins and remove the
supernatant.
XI. Resuspend in 1 ml of buccal cell buffer.
XII. Perform viable cell count using haemocytometer
and trypan blue
XIII. Centrifuge at 100 g for 10 min.
PAUSE POINT: Cells can be resuspended in 200 μl
PBS and taken through to DNA isolation or if sto-
rage required proceed to step XIV.
XIV. Discard supernatant and resuspend the cell pel-
let in freezing media (FBS and 10%DMSO) resus-
pend at 5 × 10
6 cells/ml
XV. Place in Styrofoam box at -80degC.
XVI. Transfer to Liquid Nitrogen for long term sto-
rage until required
a. Cells can be stored for up to 10 years.
XVII. To thaw cells, remove from liquid nitrogen
and place on ice
XVIII. Place vial in a beaker of 37degC water and
agitate gently.
XIX. Once completely thawed, centrifuge vial for 5
min at 300 g.
XX. Discard supernatant and resuspend pellet in 200
μl PBS
Tissue culture
I. Centrifuge appropriate number of cells for 5 min
at 300 g.
PAUSE POINT: Cells can be resuspended in 200
μl PBS and taken through to DNA isolation or if
storage required proceed to step XIV.
II. Discard supernatant and resuspend the cell pellet
in freezing media (FBS and 10%DMSO) resuspend at
5×1 0
6 cells/ml
III. Place in Styrofoam box at -80degC.
IV. Transfer to Liquid Nitrogen for long term sto-
rage until required
a. Cells can be stored for up to 10 years.
V. To thaw cells, remove from liquid nitrogen and
place on ice
VI. Place vial in a beaker of 37degC water and agi-
tate gently.
VII. Once completely thawed, centrifuge vial for 5
min at 300 g.
VIII. Discard supernatant and resuspend pellet in
200 μl PBS
Other tissues (e.g. biopsy material)
I. Collect biopsy sample in 3 ml RPMI in a sterile
tube.
II. Transfer sample to a new sterile tube containing
3 ml RPMI with forceps. Mix by inversion. Repeat
twice.
III. Transfer sample to cryovial containing 900 μl
FBS with forceps.
PAUSE POINT: Cells can be resuspended in 200
μl PBS and taken through to DNA isolation or if
storage required proceed to step XIV.
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in freezing media (FBS and 10%DMSO) resuspend at
5×1 0
6 cells/ml
V. Place in Styrofoam box at -80degC.
VI. Transfer to Liquid Nitrogen for long term sto-
rage until required
a. Cells can be stored for up to 10 years.
VII. To thaw cells, remove from liquid nitrogen and
place on ice
VIII. Place vial in a beaker of 37degC water and agi-
tate gently.
IX. Once completely thawed, centrifuge vial for
5 min at 300 g.
X. Discard supernatant and resuspend pellet in
200 ul PBS
DNA isolation
Prepare samples according to protocols above; you
should have 200 μl of cell suspension in a microfuge
tube. DNA isolation is performed as per manufacturer’s
directions (Qiagen, DNeasy Blood and Tissue Kit) with
slight modifications.
1. Add 20 μl proteinase K (600 mAU/ml).
2. Add 180 μl Buffer AL (tissue and cell lysis buffer).
3. Mix by inversion 10-15 times.
4. Incubate at 37degC.
a. 3 hrs for lymphocytes and cultured cells
b. 6 hrs for tissue samples or until tissue is com-
pletely lysed
c. Optional - if tissue is not completely lysed add
additional 200 μl Buffer AL
5. Add 200 μl Ethanol.
6. Mix by inversion.
7. Incubate at room temperature for 3 minutes.
8. Pipette mixture into spin column.
9. Centrifuge at >6000 × g for 1 minute.
10. Discard flow through.
11. Pipette 500 μl Buffer AW1 (wash buffer) into
column.
12. Centrifuge at >6000 × g for 1 minute.
13. Discard flow through.
14. Pipette 500 μl Buffer AW2 (wash buffer) into
column.
15. Centrifuge at >6000 × g for 1 minute.
16. Discard flow through.
17. Centrifuge at >6000 × g for 2 minutes.
18. Transfer spin column to clean microfuge tube.
19. Pipette 200 μl Buffer AE (elution buffer) into
spin column.
20. Incubate at room temperature for 1 minute.
21. Centrifuge at >6000 × g for 2 minutes.
22. Pipette eluate back onto spin column.
23. Incubate at room temperature for 1 minute.
24. Centrifuge at >6000 × g for 2 minutes.
25. Add 1 mM DTT to eluate.
26. Store until required
PAUSE POINT.
a. store at 4degC if DNA to be used within 1 week
b. store at -20deg if DNA to be used within
2-6 weeks
c .s t o r ea t- 8 0 d e gi fD N Ai sn o tt ob eu s e df o r
2 months
d. CRITICAL - minimise times stock DNA is
freeze-thawed
27. DNA was quantified in triplicate using a Nano-
Drop spectrophotometer.
a. Yield and quality of DNA will vary depending
on input material
b. 5 × 10
6 lymphocytes or cultured cells should
yield 10-20 μgo fD N A ;5×1 0
5 buccal cells
approximately 1-5 μg DNA.
c. Pure DNA has a A260/280 ratio of 1.7-2.0
Normalisation plate
To reduce pipetting error in qPCR assay we generate a
working concentration DNA plate. This plate includes
DNA samples to be examined all at a consistent 5 ng/μl.
Plan carefully the layout of this plate, to minimise effect
of plate to plate variation, ensure samples from same
individual are on a single plate
28. set up normalisation plate at 5 ng/μl
a. dilute concentrate DNA samples with PCR
grade water (DNase/RNase Free) into 96-well
plate
b. make enough to complete required PCR reac-
tions (minimum 50 μl - maximum 200 μl)
29. Store plate at 4degC until required
a. Diluted DNA can be stored up to 1 year at
4degC
qPCR for aTL
All samples are run on an ABI 7300 Sequence Detection
System with the SDS Ver. 1.9 software (Applied Biosys-
tems [AB] Foster City, CA).
30. Prepare master mix solution (Table 2). Prepare
enough for samples to be run in triplicate, no tem-
plate control (NTC), positive control (1301 cell line
DNA), standards (which should be run on every
plate) plus an extra 5% for pipetting error.
a. For example a 96-well plate set up is described
in Table 3
31. Mix well and briefly centrifuge
32. Pipette required amount (16 ul in our example)
of master mix into each well of the PCR plate
a. The power SYBR Green has a high detergent
content so pipette master mix carefully to avoid
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mix
33. Remove from PCR set-up hood
34. Pipette required volume of DNA into all sample
wells
a. TAKE CARE - this pipetting step must be
done with great care and precision
35. Pipette required volumes of standards, positive
c o n t r o la n dw a t e rf o rN T Ci n t ot h e i rr e s p e c t i v e
wells.
36. Seal plate with optical clear film
37. Centrifuge briefly
38. Pause Point
a. Samples can be stored at 4degC O/N if
required
Running the PCR (Timing: 2 hrs)
39. Turn on PCR machine
40. Input sample identifiers on qPCR running soft-
ware, including NTC, positive control and quantities
of standards (i.e. TEL STD A = 1.18 × 10
8 kb telo-
mere..etc)
41. Cycling conditions (for both telomere and 36B4
amplicons) are: 10 min at 95°C, followed by 40
cycles of 95°C for 15 sec, 60°C for 1 min, followed
by a dissociation (or melt) curve.
42. Once PCR has completed - remove plate and
discard
QC of results (TIMING 0.5 hrs)
43. Check for appropriate amplification in positive
control and no signal in NTC
44. Observe amplification in standards and samples
45. Setting baseline. Because TEL STD A will amplify
v e r ye a r l y( a ta p p r o x .C t5 )y o um a yn e e dt oa l t e r
background parameters on the qPCR output window.
46. Standard curve. Check standard curve by using
results from TEL STD A dilutions. Using these con-
centrations you should observe the linear range of
the reaction.
47. Ensure all target samples fall within the linear
range - any samples that amplify outside this linear
range should be removed from further analysis.
48. Check replicates for variation. Individual samples
are analysed in triplicate and accepted only if the
standard deviation of the Ct values are <1Ct (CV >
5%). It is expected that 90% of samples analysed will
meet this criterion. Samples with differences in stan-
dard deviation greater than 1 Ct values should be
removed from further analysis and re-analysed.
49. After amplification is completed the AB software
produces a value for each reaction that is equivalent
to kb/reaction based on the telomere standard curve
values.
qPCR for SCG
50. Repeat from step 30 with single copy gene pri-
mers in reaction.
a. This value generate from SCG will be number
of genome copies per reaction
Processing and analysing data
51. Export values (kb/reaction for telomere and gen-
ome copies/reaction for SCG) to csv format
52. The kb/reaction value is then used to calculate
total telomere length in kb per human diploid genome.
53. The telomere kb per reaction value is divided by
diploid genome copy number to give a total telo-
meric length in kb per human diploid genome.
54. OPTIONAL: This value can be further used to
give a length per telomere by dividing by 92 (92 is
the total number of telomeres on 23 pairs of chro-
mosomes found in normal human cells).
QC and comparison with other methods for measuring
telomere length
DNA from the 1301 lymphoblastic cell line can be used
as a long telomere control (telomere length of 70 kb) in
each plate run. The inter- and intra- experimental coef-
ficient of variation of the 1301 telomere length measure-
ment by absolute qPCR should be less than 7% and 2%,
respectively.
The performance of the qPCR method for aTL it can
be tested by comparison to the gold standard of telo-
mere length measurements, Terminal Restriction
Table 3 Example of reaction plate set up using 24
samples
1 2 3 4 5 6 7 8 9 10 11 12
A 111 9 9 91 71 71 7 S 1 S 1 S 1
B 2 2 2 10 10 10 18 18 18 S2 S2 S2
C 3 3 3 11 11 11 19 19 19 S3 S3 S3
D 4 4 4 12 12 12 20 20 20 S4 S4 S4
E 5 5 5 13 13 13 21 21 21 S5 S5 S5
F 6 6 6 14 14 14 22 22 22 S6 S6 S6
G 7 7 7 15 15 15 23 23 23 POS POS POS
H 8 8 8 16 16 16 24 24 24 NTC NTC NTC
All numbers refer to replicates of an individual sample; POS = positive control;
1301 cell line DNA; NTC = no template control; S1 = TEL STD A (= 1.18 × 10
8);
S2 = TEL STD B (= 1.18 × 10
7); S3 = TEL STD C (= 1.18 × 10
6) etc...
Table 2 Representation of master mix preparation
Reagents Volumes for one
sample (ul)
Final
concentration
Power SYBR Green master
mix (2x)
10 1x
Primer (telomere-fwd (2
μM))
1 0.1 μM
Primer telomere-rev (2 μM) 1 0.1 μM
H204
DNA (5 ng/μl DNA) 4 20 ng total
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Page 7 of 10Fragment analysis (TRF) [32]. Telomere lengths are
determined by a TRF diagnostic kit (Roche Diagnostics,
Australia). For example our studies demonstrated a
strong correlation between results for TRF and the
qPCR method for aTL (r
2 = 0.75, p < 0.0001) (Figure 2).
The TRF measurement for the 1301 B-cell derived lym-
phoblastoid cell line, commonly used in Flow-FISH ana-
lysis of telomere length was reported to be 80 kb [33].
Using the absolute Real-Time PCR method, we measure
the average telomere length for 1301 at 70 kb.
Telomere lengths, in different cell types, showed good
agreement between the reported TRF values and the
measures we obtained by the absolute qPCR method
(Figure 2). However, there is a consistent discrepancy
between the values obtained by the two methods with
the TRF value being approximately 7 kb greater than
that observed with the aTL [33-35]. It is recognised that
the TRF method tends to overestimate telomere length
because there is a considerable, highly variable, non-
telomeric DNA component within TRFs [36]. In con-
trast, aTL only detects and amplifies intact TTAGGG
sequences (Figure 3). In addition to TTAGGG, terminal
restriction fragments in human DNA contain variable
amounts of TTAGGG-like repeat sequences, which are
detected as telomere sequence in the TRF assay. These
include telomere repeat variants proximal to the telo-
mere and the telomere adjacent sequences (reviewed in
[36]). Additionally, as TRF is based on hybridisation the
shorter the telomere the lower the hybridisation signal,
consequently there is a telomere length threshold below
which TRF analysis will not detect telomeric DNA.
Although TRF analysis biases towards longer TL, this
can be partially corrected by dividing the signal intensity
by length in base pairs [37], although this is not always
done.
Trouble shooting advice
1. Low quality DNA/low yield. There are several possi-
ble causes for low yield/quality DNA. The most com-
mon reasons include inappropriate storage of sample
following collection, non optimal starting amount (too
much or too little) of sample collected, and insufficient
cell lysis. Suggestion: Reisolate DNA from starting
material.
2. Low/no amplification in PCR (positive controls
and standards). There are several possible causing for
low/no PCR amplification. Suggestion:C h e c kp r i m e r
dilutions, you may need to set up fresh working dilu-
tions of primers from oligomer stock.
3. Polymerase not working efficiently. Suggestion:
Check PCR cycling to ensure appropriate activation of
DNA polymerase is in place; select new aliquot of mas-
ter mix and repeat PCR.
4. Fluorescent dye not working. Suggestion:C h e c k
PCR machine setting to ensure appropriate detection
method for SYBR Green is selected; select new aliquot
of master mix and repeat PCR.
5. Low/no amplification in PCR (samples).
a. low quality DNA (see above)
b. too much/too little DNA used (see Variation in
Copy Number for expected results and modify
accordingly)
6. Amplification in NTC. It is important that you
determine the cause of this amplification; results from
plates with NTC amplification should not be used. Sug-
gestion: First check dissociation curve plot to determine
likely causes of amplification in NTC; gDNA contamina-
tion or primer dimer formation. If cause of amplification
in NTC is contamination (usually in the PCR set-up)
change water and repeat NTC. Primer dimer formation
is another cause of signal in the NTC wells. This ampli-
fication can be identified via examination of the disso-
ciation curve; primer dimmer dissociation curves will
appear very different to telomere dissociation profiles.
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Figure 2 Comparison of telomere length measurement
methods. Graph represents correlation between the TRF and aTL
methods. Telomeres were measured in whole-blood, lymphocytes,
mid-rectal biopsies and low and high controls (Telo-assay, Roche)
(r
2 = 0.75, p < 0.0001).
Figure 3 Schematic representation of aTL measurement by
qPCR. One pair of chromosomes is shown, circles represent
centromeres. Regions containing telomere repeats (TTAGGG)n are
coloured blue. As shown, telomere lengths can vary between
chromosomes and even between the two ends of a single
chromosome. The arrows represent the primer pairs used to amplify
the telomere sequences. The telomere PCR signal is a measure of
telomere length, because the number of telomere primers that can
bind the telomeric DNA at the beginning of the PCR is directly
proportional to the total summed length of all the telomeres in the
cell (adapted from [38]).
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Page 8 of 10Anticipated results
A typical data set from lymphocytes and buccal cells of
18 males and 25 females in a young group (aged 18-31
years), and 25 males and 23 f e m a l e si na no l d e rg r o u p
(65-75 yrs) is shown in Figure 4. For the young group the
lymphocytes had a mean aTL of 97.2 kb/diploid genome
(range 35-260); the buccal cells had a mean aTL of 211.2
kb/diploid genome (range 45-594). The lymphocytes
from the older group had a mean aTL of 86.6 kb/diploid
genome (range 35-174); the buccal cells had a mean aTL
of 230 kb/diploid genome (range 33-750).
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